First oral treatment, Paxlovid, authorized for emergency use

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for Paxlovid for the treatment of mild-to-moderate COVID-19 in adults and children over 12. Paxlovid is covered for TRICARE beneficiaries if ordered by a provider.